Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B C Carleton

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
The Pharmacogenomics Journal|April 17, 2013
Higher frequency of genetic variants conferring increased risk for ADRs for commonly used drugs treating cancer, AIDS and tuberculosis in persons of African descentF Aminkeng, C J D Ross, S R Rassekh, et al.
Pediatric Blood & Cancer|February 27, 2013
Validation of variants in SLC28A3 and UGT1A6 as genetic markers predictive of anthracycline-induced cardiotoxicity in childrenH Visscher, C J D Ross, S R Rassekh, et al.
The Pharmacogenomics Journal|May 28, 2014
Pharmacogenomic diversity in Singaporean populations and EuropeansL R Brunham, S L Chan, R Li, et al.
NPJ Precision Oncology|July 15, 2021
TCERG1L allelic variation is associated with cisplatin-induced hearing loss in childhood cancer, a PanCareLIFE studyA J M Meijer, F A Diepstraten, T Langer, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
The Pharmacogenomics Journal|April 17, 2013
Higher frequency of genetic variants conferring increased risk for ADRs for commonly used drugs treating cancer, AIDS and tuberculosis in persons of African descentF Aminkeng, C J D Ross, S R Rassekh, et al.
Pediatric Blood & Cancer|February 27, 2013
Validation of variants in SLC28A3 and UGT1A6 as genetic markers predictive of anthracycline-induced cardiotoxicity in childrenH Visscher, C J D Ross, S R Rassekh, et al.
The Pharmacogenomics Journal|May 28, 2014
Pharmacogenomic diversity in Singaporean populations and EuropeansL R Brunham, S L Chan, R Li, et al.
NPJ Precision Oncology|July 15, 2021
TCERG1L allelic variation is associated with cisplatin-induced hearing loss in childhood cancer, a PanCareLIFE studyA J M Meijer, F A Diepstraten, T Langer, et al.
Pageof 3